Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1996)
A critical role for transforming CD 25 a subpopulations
(2001)
autoreactivity in the absence of CD40-CD40 cell traffic control: in vivo evidence that 35
(2000)
Enk 82. Seddon B, Mason D. Regulatory T cells in the
Powrie F , Mauze S , Coffman RL
(1998)
; 28 : 3435 – 3447 . Transplantation 1999 ; 68 : 1891 – 1897
(1994)
inhibiting interleukin 2 production
(1997)
expansion of peripheral CD4 T cells through
(1995)
Schimpl Activated self-MHC-reactive T cells have the A. Normal clonal expansion but impaired dependent mechanism. cytokine phenotype of Th3/T regulatory Fas-mediated cell death and anergy
Andrew Weinberg, Anthony Vella, Michael Croft (1998)
OX-40: life beyond the effector T cell stage.Seminars in immunology, 10 6
(2000)
Prevention of experimental prevent diabetes onset in nonobese diabetic colitis in SCID mice reconstituted with inhibition of GATA-3 expression. mice. CD45RB high CD4 π T cells by blocking the
(1991)
Engagement of Nature 1991;352:621–624
(2000)
Animal models of M. Ox-40 ligand: a potent costimulatory differentiation and autoimmune disease. autoimmunity and their relevance to human molecule for sustaining primary CD4
A CD4 π T-cell subset inhibits receptor
(2001)
Induction of tolerance by IL - 10 - cells
(1997)
Lymphoproliferative 27
Seddon B, Mason D. The third function of dendritic cells
(1998)
Immunologic selfInt Immunol 1998;10:371–378
Interleukin-10-deficient mice 21. Stephens LA, Mason D. CD25 is a marker for 5
(1995)
Inhibition of Th1 responses Thornton AE, Shevach EM. CD4 π CD25 π disease: protective and pathogenic roles. prevents inflammatory bowel disease in scid Immunoregulatory T cells suppress
(1995)
Human anergic/ chronic mucosal inflammation. 4 leads to massive lymphoproliferation and suppressive CD4 π CD25 π T cells: a highly
(1996)
growth factor-b but not interleukin 4 in the
(1998)
Disruption of T cell homeostasis in mice 78. Roncarolo MG, Levings MK. The role of 61. expressing a T cell-specific dominant
(2000)
Helicobacter hepaticus murine kalaazar. proliferation of CD4 π T cells. triggers colitis in specific-pathogen-free
(1995)
1995;155:1151–1164. levels of CD45RB induce wasting disease
(1999)
Regulatory T cells in and TNF dependence
(1997)
Altered immune Toda M . Immunologic self - tolerance chronic intestinal inflammation in C . B - 17 responses in interleukin 10 transgenic mice . maintained by activated T cells expressing SCID mice
(1999)
inhibition of effector T cell function in requirements for regulation of autoimmune 67. humans after injection of immature dendritic
(1995)
Regulatory interactionsMorrissey PJ , Charrier K , Braddy S , Liggitt causes various autoimmune diseases . D , Watson JD
(1998)
1999;163:5211–5218. conditional on interferon g expression by T cells
(2001)
The third function of dendritic cells . Bandeira A . CD 25 π CD 4 π T cells regulate the the thymus
(1999)
Phenotypically distinct subsets
(1993)
TGF-b) production by murine CD4 π disease in mice with a disrupted interleukin-Powrie F, Schauer DB. Inflammatory bowel T cells. 2 gene. disease: an immunity-mediated condition
(2000)
molecule related to nerve growth factor
(1995)
CD4 π T cells reactive to enteric deficient in CTLA-4. expression of IL-2R a chain, resistance to bacterial antigens in spontaneously colitic
(2000)
Abrogation of TGF-b
(1999)
hosts depends on their state of activation, ILdevelopmental abnormality of a T cell
(2000)
Uncoupling of thymocytes . inflammatory chemokine receptors by IL - 10 : 74
(1995)
Innate a critical negative regulatory role of CTLA - 4 . population .
(1991)
Normal luminal bacteria, cytotoxic T lymphocyte-associated antigen 4. in mice rendered interleukin-2 deficient by especially Bacteroides species, mediate chronic
(1996)
IL-10 is required for RL, Powrie F. An essential role for colitis by CD45RB low CD4 π T cells. regulatory T cells to mediate tolerance to interleukin 10 in the function of regulatory
(1997)
Generalized autoimmune Wilson ME , DosReis GA . TGF - b mediates disease in interleukin - 2 - deficient mice is
(2000)
Differential cytokine Nat Immunol 2000;1:387–391
J Immunol 2001 ; 166 : 3789 – 3796
different subsets of T regulatory cells in Characterization of the MRC OX40 antigen of negative transforming growth factor-b II controlling autoimmunity
(1997)
Treatment of experimental colitis . 62 . ( trinitrobenzene sulfonic acid ) colitis byWalker LS , et al . Compromised OX 40 Nature
CD38 π CD45RB low 23
Induction of interleukin 10-producing, control of autoimmunity: the essential role of 65. nonproliferating CD4 π T cells with
(1993)
diabetes in rats, but peripheral T cells with C.B-17 SCID mice reconstituted with the 14
tolerance maintained by CD25 π CD4 π
(1993)
IL-2 receptor a-chains (CD25)
(1998)
through an IL - 12 - and g interferon - Kneitz B , Herrmann T , Yonehara S , Schimpl Activated self - MHC - reactive T cells have the A . Normal clonal expansion but impaired dependent mechanism
(2001)
Expression 34
(1990)
antigen - specific T - cell responses and prevents
Summary: Transfer of CD4+ T cells to immune‐deficient mice in the absence of the CD25+ subset leads to the development of colitis, indicating that regulatory cells capable of controlling a bacteria‐driven inflammatory response are present in normal mice. Cells with this function are present in the thymus as well as in the periphery of germ‐free mice, suggesting they may be reactive with self‐antigen. These cells resemble CD4+CD25+ cells that inhibit organ‐specific autoimmunity, suggesting that a similar subset of regulatory T cells may control responses to self and foreign antigens. Development of colitis is dependent on accumulation of activated CD134L+ dendritic cells (DC) in the mesenteric lymph nodes, which is inhibited by CD4+CD25+ cells, indicating that regulatory T cells may control DC activation in vivo. Whilst inhibition of T‐cell activation in vitro by CD4+CD25+ cells does not involve interleukin‐10 and transforming growth factor‐β, these cytokines are required for the suppression of colitis. It may be that control of responses that activate the innate immune system requires multiple mechanisms of immune suppression. Recently, we identified CD4+CD25+ cells with immune suppressive activity in the thymus and peripheral blood of humans, raising the possibility that dysfunction in this mechanism of immune regulation may be involved in the development of autoimmune and inflammatory diseases.
Immunological Reviews – Wiley
Published: Jan 1, 2001
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.